| Literature DB >> 35417715 |
Shyh-Chi Chen1, Xin Tang1, Tadahiro Goda2, Yujiro Umezaki2, Abigail C Riley1, Manabu Sekiguchi3, Taishi Yoshii3, Fumika N Hamada4.
Abstract
Animals display a body temperature rhythm (BTR). Little is known about the mechanisms by which a rhythmic pattern of BTR is regulated and how body temperature is set at different times of the day. As small ectotherms, Drosophila exhibit a daily temperature preference rhythm (TPR), which generates BTR. Here, we demonstrate dorsal clock networks that play essential roles in TPR. Dorsal neurons 2 (DN2s) are the main clock for TPR. We find that DN2s and posterior DN1s (DN1ps) contact and the extent of contacts increases during the day and that the silencing of DN2s or DN1ps leads to a lower temperature preference. The data suggest that temporal control of the microcircuit from DN2s to DN1ps contributes to TPR regulation. We also identify anterior DN1s (DN1as) as another important clock for TPR. Thus, we show that the DN networks predominantly control TPR and determine both a rhythmic pattern and preferred temperatures.Entities:
Keywords: CP: Neuroscience; anterior dorsal neurons 1; body temperature rhythms and Drosophila melanogaster; circadian clock; circadian rhythms; dorsal neurons 2; posterior dorsal neurons 1; temperature homeostasis; temperature preference rhythms; thermoregulation
Mesh:
Substances:
Year: 2022 PMID: 35417715 PMCID: PMC9109596 DOI: 10.1016/j.celrep.2022.110668
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995
Figure 1.DN2s, but not DN1ps, are the main clock neurons for the daytime TPR
(A–E) Comparison of the TPR between the flies with clock disruption or silencing (orange) and the control flies (Gal4 [black] and UAS [gray]). Clock disruption by the expression of tim in DN1ps (A) and DN2s (D). Neuronal silencing using UAS-Kir with R18H11-Gal4 (DN1p-specific) (B), spl-gDN1-Gal4 (DN1p-specific) (C), and Clk9M-G4;PDF-G80 (DN2s-specific) (E).
(F) Schematic showing that DN2s and DN1ps are likely in the same pathway for TPR regulation. The numbers in the graphs represent the number of assays. The daytime TPR data were analyzed using one-way ANOVA and Tukey’s honestly significant difference post hoc test, and the data were compared with the Tp at ZT 1–3 (Table S1): **p < 0.01 and *p < 0.05. The Tp in experimental and control flies was compared at each time point using one-way ANOVA and Tukey’s honestly significant difference post hoc test: green *p < 0.05 for both controls and ns refers to not significant, which are shown below the x axis (Table S2).
Figure 2.DN2s contact DN1ps
(A) Representative image of the Clk9M-Gal4/UAS-mCD8:GFP;PDF-Gal80/+ brain at ZT 11. DNs were immunostained by an anti-VRILLE (VRI) antibody (red). GFP is selectively expressed in DN2s (green; shown in arrowheads).
(B–E) Representative image of the GRASP signals. The reconstituted GFP signals (GRASP GFP; green; shown as arrows in C and E) were detected (B, magnified in C–E). The soma and projection of DN2s (red) were stained with an anti-GFP antibody against spGFP1–10 expressed from a DN2 driver (D).
(F–H) The GRASP signals were measured as the GFP fluorescence intensity and compared throughout the day (F). The numbers in the graphs represent the number of GRASP experiments. One-way ANOVA and Tukey-Kramer post hoc tests were used to compare the GFP fluorescence intensity at different times with that at ZT 1–4 (Table S3). Representative images of GRASP signals at ZT 3 (G) and ZT 15 (H). More and brighter contacts showed by the arrows were observed between DN2s and DN1ps at ZT 15 than at ZT 3.
(I and J) Representative graphs of DN1p activation via P2X2 expression in DN2s. GCaMP3.0 and P2X2 were expressed in DN1ps and DN2s, respectively. The representative trace of GCaMP fluorescence in DN1ps after the bath application of 3 mM ATP (J) or the vehicle control (I).
(L and M) Representative graphs of DN2 activity induced by P2X2 expression in DN1ps. GCaMP3.0 and P2X2 were expressed in DN2s and DN1ps, respectively. The representative trace of GCaMP fluorescence in DN2s through the bath application of 3 mM ATP (M) or the vehicle control (L). (K, N) The bar graphs show the mean maximum increases in GCaMP fluorescence in DN1ps (K) and DN2s (N) after the bath application of ATP or vehicle control. An unpaired t-test was used. The numbers in the graphs represent the number of experiments, and the experiments were performed from ZT 5–12.
Figure 3.DN2 hyperactivation causes the abnormal daytime TPR
TPR in DN2-hyperexcited flies. Hyperexcitation in DN2s was induced by the expression of UAS-dnATPase (A) and UAS-Shaw-RNAi (B) using Clk9M-G4;PDF-G80 (Table S1). The Tp at each ZT was compared with those at ZT 1–3 using one-way ANOVA and Tukey’s honestly significant difference post hoc test.
Figure 4.The clock disruption or neural silencing in DN1as causes the abnormal TPR
(A–D) The TPR curves observed after clock disruption induced by the expression of tim (A, B) or neuronal silencing induced by the expression of UAS-Kir2.1 (C, D) in DN1as (orange lines). The following Gal4 lines targeting DN1as were used: (A, C) spl-DN1a-G4 (1), (B, D) spl-DN1a-G4 (2). The TPR data were compared with those at ZT 1–3 using one-way ANOVA and Tukey’s honestly significant difference (HSD) post hoc test (Table S1). The Tp setpoints in experimental and control flies were compared at each time point using one-way ANOVA and Tukey’s HSD post hoc test: green *p < 0.05 for both controls and ns refers to not significant, which are shown below the x axis.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
|
| ||
| Antibodies | ||
|
| ||
| Rabbit anti-GFP | Invitrogen | Cat# A-6455; RRID: AB_221570 |
| Guinea pig anti-VRI | Dr. Paul Hardin | |
| Rat anti-TIM | Dr. Michael Rosbash | |
| Rabbit anti-CCHa1 | Dr. Taishi Yoshii ( | |
| Rabbit anti-CD4 | Abcam | Cat# ab133616; RRID: AB_275088 |
| Donkey anti-rat-Alexa Fluor 488 | Jackson IR | Cat# 712-545-153; RRID: AB_2340684 |
| Donkey anti-guinea pig-Alexa Fluor 647 | Jackson IR | Cat# 706-605-148; RRID: AB_2340476 |
| Donkey anti-rabbit-Cy5 | Jackson IR | Cat# 711-175-152; RRID: AB_2340607 |
|
| ||
| Chemicals, peptides, and recombinant proteins | ||
|
| ||
| HEPES | Sigma | H3375 |
| NaCl | Fisher scientific | BP358-10 |
| KCl | Fisher scientific | BP366-500 |
| CaCl2 | Sigma | C7902 |
| MgCl2 | Fisher scientific | BP214-500 |
| NaHCO3 | Sigma | S5761 |
| Trehalose | Acros organics | 182550250 |
| Glucose | Sigma | G6152 |
| Sucrose | Sigma | S0389 |
| Fructose | AMRESCO | 0226-2.5KG |
| Lactose | Sigma | L3625 |
|
| ||
| Experimental models: Organisms/strains | ||
|
| ||
| Drosophila: Clk4.1M-Gal4 | Bloomington Drosophila Stock Center ( | RRID: BDSC_36316 |
| Drosophila: R18H11-Gal4 | Bloomington Drosophila Stock Center ( | RRID: BDSC_48832 |
| Drosophila: spl-gDN1-Gal4 (R20G07-p65.AD;R18H11-G4.DBD) | Dr. Gerald M. Rubin ( | |
| Drosophila: UAS-Kir2.1 | Dr. Michael Bate ( | |
| Drosophila: timCRISPR (UAS-sgRNA-tim3x; UAS-Cas9.2) | Dr. Mimi Shirasu-Hiza | |
| Drosophila: Clk9M-Gal4;PDF-Gal80 | Hamada Lab | |
| Drosophila: UAS-P2X2 | Dr. Orie Shafer | |
| Drosophila: UAS-GCamp3.0 | Bloomington Drosophila Stock Center | RRID: BDSC_32116 |
| Drosophila: Clk4.1M-LexA | Bloomington Drosophila Stock Center | RRID: BDSC_80704 |
| Drosophila: LexAop-GCamp3.0 | Dr. Orie Shafer | |
| Drosophila: LexAop-P2X2 | Dr. Orie Shafer | |
| Drosophila: UAS-P2X2 | Dr. Orie Shafer | |
| Drosophila: UAS-dnATPase | Dr. Leslie Griffith | |
| Drosophila: UAS-Shaw RNAi | Dr. Leslie Griffith | |
| Drosophila: spl-DN1a-Gal4(1) (VT04317-p65.AD;R93B11-G4.DBD) | Dr. Taishi Yoshii ( | |
| Drosophila: spl-DN1a-Gal4(2) | Bloomington Drosophila | RRID: BDSC_70601 |
| R23E05-p65.AD R92H07-Gal4.DBD | Stock Center ( | RRID: BDSC_70004 |
| Drosophila: UAS-tim RNAi (kk) | Vienna Drosophila Resource Center | 101100 |
| Drosophila: LexAop-CD4-spGFP11 | Dr. Kristin Scott | |
| Drosophila: UAS-CD4-spGFP1-10 | Dr. Kristin Scott | |
|
| ||
| Software and algorithms | ||
|
| ||
| ImageJ | National Institutes of Health | RRID: SCR_002285 |
| Imaris | Bitplane | RRID: SCR_007370 |
| AxioVision | ZEISS | RRID: SCR_002677 |
| GraphPad Prism (v 7.02) | Graphpad Software | RRID: SCR_002798 |